1 |
67 |
M |
MOE |
3.5 |
18 |
6.4 |
29 |
27 |
28 |
29 |
28 |
51 |
59 |
99 |
102 |
Not done |
No |
No growth |
Itraconazole/ piptaz/ciplox |
Yes |
3 months |
2 |
76 |
M |
Central SBO |
0.5 |
32 |
71 |
26 |
7 |
2 |
7 |
25 |
81 |
74 |
72 |
44 |
Yes |
No |
Aspergillus flavus |
Inj fortum/ voricoazole/ ciplox |
Yes |
4 months |
3 |
53 |
M |
Central SBO |
11 |
20 |
13 |
9 |
4 |
4 |
55 |
55 |
56 |
40 |
36 |
10 |
Yes |
Yes |
Klebsiella |
Linezolid and vancomycin, magnex voriconazole, meropenem, minocycline |
Yes |
3 months |
4 |
62 |
F |
Central SBO |
23 |
30 |
38 |
20 |
15 |
9 |
91 |
101 |
83 |
56 |
34 |
30 |
Yes |
No |
No culture |
Ceftazidime, amikacin and metrogyl, IV magnex and oral linezolid and voriconazole, piptax and ciplox |
Yes |
6 weeks |
5 |
65 |
M |
Central SBO |
24 |
117 |
68 |
23 |
21 |
14 |
107 |
108 |
113 |
108 |
97 |
50 |
Yes |
No |
No growth |
Piperacillin, voriconazole |
Yes |
Lost for follow up |
6 |
61 |
M |
Central SBO |
91 |
74 |
54 |
63 |
47 |
34 |
56 |
74 |
61 |
34 |
67 |
54 |
Yes |
No |
Aspergillus flavus |
Voriconazole |
Yes |
5 months |
7 |
64 |
F |
Central SBO |
13 |
10 |
9 |
4 |
3 |
2 |
19 |
52 |
54 |
43 |
40 |
38 |
Yes |
Yes |
Chryosporim, Pseudomonas acruginosa |
Ceftazidime, voriconazole, ciprofloxacin, fluconazole |
Yes |
2 months |
8 |
55 |
M |
Central SBO |
24 |
110 |
68 |
23 |
21 |
14 |
98 |
108 |
103 |
108 |
97 |
50 |
Yes |
No |
No culture |
Ceftazidime |
No |
2 months |
9 |
70 |
M |
Central SBO |
11 |
20 |
13 |
9 |
4 |
4 |
55 |
55 |
56 |
40 |
36 |
30 |
Yes |
Yes |
No culture |
Piperacillin |
No |
Passed away |
10 |
73 |
M |
Central SBO |
25 |
21 |
16 |
10 |
5 |
2 |
95 |
104 |
87 |
60 |
54 |
43 |
Yes |
No |
Candida para psilosis |
Voriconazole, piperacillin, meropenem |
Yes |
6 weeks |
11 |
45 |
M |
Central SBO |
24 |
21 |
15 |
8 |
3 |
1 |
67 |
80 |
57 |
65 |
45 |
14 |
Yes |
No |
Staph aureus |
Voriconazole, piperacillin, clindamycin, cloxacillin, linezolid, ciprofloxacin |
Yes |
On antibiotics for 1 yr and a month, patient had symptomatic relief after 2 months |
12 |
78 |
M |
MOE |
40 |
32 |
25 |
20 |
15 |
5 |
90 |
74 |
70 |
35 |
44 |
52 |
Yes |
No |
Pseudomonas, Candida Albinas |
Ciprofloxacin and cefaperazone |
No |
2 months |
13 |
60 |
M |
Central SBO |
0.7 |
3.6 |
4 |
4.2 |
3 |
3.3 |
70 |
96 |
103 |
97 |
88 |
58 |
Yes |
No |
Enterococcus fecalis |
Ceftazidime, ciprofloxacin, piperacillin, linezolid, fluconazole |
Yes |
Lost for follow up |
14 |
66 |
F |
MOE |
40 |
43 |
38 |
21 |
22 |
4 |
70 |
34 |
42 |
68 |
52 |
34 |
Yes |
No |
No growth |
Ceftazidime, ciprofloxacin, voriconazole |
No |
Lost for follow up after 6 months IV and voriconazole |
15 |
66 |
M |
MOE |
1.5 |
5.1 |
4 |
2.3 |
1.9 |
0,7 |
40 |
73 |
57 |
52 |
40 |
46 |
Yes |
No |
Gram negative bacteria |
Piperacillin voriconazole, itraconazole |
No |
2 months |
16 |
78 |
M |
MOE |
20 |
17 |
10 |
9 |
9.2 |
1 |
60 |
61 |
58 |
44 |
30 |
29 |
Yes |
No |
No growth |
Ceftazidime |
Yes |
2 months |
17 |
63 |
M |
Central SBO |
30 |
120 |
210 |
344 |
400 |
412 |
70 |
77 |
92 |
100 |
90 |
102 |
Yes |
Yes |
No growth |
Piperacillin voriconazole, clindamycin |
Yes |
Antibiotics for 1 month, expired due to septic shock |
18 |
77 |
M |
MOE |
6.5 |
16 |
22 |
30 |
32 |
23 |
54 |
44 |
40 |
36 |
28 |
18 |
Yes |
Yes |
Citrobacter kooseri, Klebsiella pneumoniae, enterococcus faecalis |
Ceftazidime, ciprofloxacin |
Yes |
2 months |
19 |
65 |
M |
MOE |
36 |
106 |
88 |
42 |
56 |
2 |
86 |
74 |
66 |
42 |
30 |
36 |
Yes |
Yes |
Pseudomonas aeruginosa |
Ciprofloxacin, piperacillin |
Yes |
2 months |
20 |
68 |
M |
Central SBO |
10 |
22 |
8.04 |
4 |
1.3 |
11 |
96 |
42 |
36 |
53 |
50 |
52 |
Yes |
Yes |
Candida hemulonii |
Meropenem, voriconazole |
Yes |
6 months |
21 |
72 |
M |
Central SBO |
47 |
79 |
13 |
31 |
26 |
23 |
96 |
107 |
97 |
90 |
88 |
80 |
Yes |
Yes |
Kodamea ohmeri |
Cefaperazone, voriconazole, amphotericin |
No |
6 months |
22 |
73 |
M |
MOE |
10 |
7.2 |
9.6 |
6 |
8 |
9.8 |
83 |
72 |
94 |
79 |
|
87 |
Yes |
Yes |
Pseudomonas aeruginosa |
Cefaperazone, ciprofloxacin, piperacillin, voriconazole |
Yes |
4 weeks of piptaz and 4 months of voriconazole |
23 |
59 |
M |
MOE |
23 |
20 |
16 |
10 |
4 |
2 |
74 |
55 |
42 |
33 |
20 |
28 |
Yes |
No |
No culture |
Piperacillin, ciprofloxacin |
No |
6 weeks |
25 |
62 |
M |
MOE |
11 |
6.1 |
5.5 |
10 |
17 |
19 |
49 |
45 |
36 |
51 |
59 |
64 |
Yes |
Yes |
Pseudomonas, Klebsiella, Streptococcus |
Piperacillin, voriconazole |
Yes |
8 months of voriconazole and 3 months of piptaz |
26 |
74 |
F |
Central SBO |
16 |
10 |
8 |
2 |
1.4 |
0.8 |
46 |
43 |
36 |
29 |
20 |
16 |
Yes |
No |
Aspergillus flavus |
Voriconazole, cefaperazone, ciprofloxacin |
No |
2 months |
27 |
72 |
M |
Central SBO |
20 |
16 |
12 |
8 |
4 |
2 |
51 |
50 |
40 |
44 |
35 |
38 |
Yes |
No |
No growth |
Ceftazidime, ciprofloxacin, piperacillin, linezolid, fluconazole |
No |
2 months |
28 |
64 |
F |
MOE |
31 |
15 |
34 |
98 |
108 |
9 |
81 |
46 |
42 |
44 |
34 |
20 |
Yes |
No |
Pseudomonas aeruginosa |
Ceftazidime |
No |
6 weeks |
29 |
61 |
M |
MOE |
7 |
16 |
18 |
15 |
93 |
1.3 |
50 |
61 |
76 |
85 |
53 |
25 |
Yes |
No |
Pseudomonas aeruginosa |
Piperacillin, cefoperazone, voriconazole |
Yes |
3 months |
30 |
71 |
M |
Central SBO |
43 |
13 |
6.5 |
6.07 |
5 |
3.2 |
69 |
81 |
68 |
40 |
42 |
38 |
Yes |
No |
No growth |
Cefaperazone, ciprofloxacin |
Yes |
2 months |
31 |
68 |
M |
Central SBO |
1.4 |
17 |
16 |
13 |
14.5 |
14 |
50 |
54 |
90 |
92 |
66 |
60 |
Yes |
Yes |
No culture |
Voriconazole, linezolid |
No |
7 weeks of voriconazole |
32 |
60 |
M |
MOE |
71 |
57 |
12.57 |
6.5 |
5.19 |
1.62 |
97 |
94 |
83 |
47 |
25 |
14 |
Yes |
No |
No growth |
Piperacillin, meropenem |
Yes |
3 months |
33 |
70 |
M |
MOE |
11.58 |
11.94 |
27 |
24 |
10 |
2.28 |
61 |
56 |
81 |
32 |
35 |
30 |
Yes |
No |
Candida non albicans (SG), Pseudomonas aeruginosa (SG) |
Voriconazole, amphotericin B, doxycycline |
Yes |
2 months |
34 |
80 |
F |
MOE |
9.3 |
19 |
5.79 |
10.85 |
9.9 |
8 |
90 |
69 |
88 |
17 |
62 |
60 |
Yes |
Yes |
No growth |
Vancomycin, meropenem, voriconazole |
No |
10 weeks |
35 |
63 |
F |
Central SBO |
8.59 |
11.19 |
10 |
9 |
6 |
5.6 |
97 |
30 |
32 |
40 |
20 |
18 |
Yes |
No |
No growth |
Ceftazidime |
No |
6 weeks |
36 |
70 |
F |
Central SBO |
17.68 |
24.46 |
67.31 |
50 |
46 |
30 |
37 |
57 |
60 |
48 |
32 |
50 |
Yes |
Yes |
Staphaureus (MG), Candida albicans |
Ceftazidime, ciprofloxacin |
No |
Lost for follow up after 4 weeks |
37 |
56 |
F |
Central SBO |
10 |
18.92 |
16 |
14 |
8.4 |
563 |
60 |
63 |
71 |
74 |
65 |
60 |
Yes |
Yes |
No culture |
Voriconazole |
No |
4 months |
38 |
54 |
M |
MOE |
4.76 |
4.7 |
11.5 |
11 |
16.8 |
4,3 |
37 |
47 |
57 |
47 |
30 |
36 |
Yes |
Yes |
Candida no albicans (MG) |
Meropenem, voriconazole |
Yes |
6 months |
39 |
62 |
M |
Central SBO |
10 |
7 |
5 |
3 |
11 |
9 |
46 |
47 |
44 |
38 |
42 |
40 |
Yes |
Yes |
Pseudomonas aeruginosa (MG) |
Ceftazidime |
No |
2 months |
40 |
75 |
M |
MOE |
3 |
2 |
54 |
15 |
2 |
0.93 |
23 |
23 |
30 |
27 |
10 |
5 |
Yes |
No |
Candida albicans |
Ceftazidime |
No |
6 weeks |
41 |
75 |
M |
MOE |
20 |
22 |
35 |
40 |
30 |
20 |
44 |
50 |
38 |
30 |
67 |
100 |
Yes |
Yes |
Aspergillus flavus, enterobacter sp. |
Ciprofloxacin, cefaperazone |
Yes |
6 months |
42 |
73 |
M |
MOE |
11 |
31 |
20 |
14 |
9.14 |
1.66 |
103 |
100 |
100 |
115 |
80 |
70 |
Yes |
Yes |
Invase aspergillosis |
Ciprofloxacin, cefaperazone |
Yes |
2 months |
43 |
71 |
M |
MOE |
8.38 |
17.26 |
22.4 |
20 |
15 |
13.2 |
30 |
80 |
54 |
40 |
60 |
76 |
Yes |
Yes |
No growth |
Ciprofloxacin, ceftazidime |
Yes |
< 8 months |
44 |
75 |
M |
Central SBO |
66 |
54 |
6.8 |
2.1 |
4 |
5 |
12 |
15 |
8 |
14 |
7 |
6 |
Yes |
No |
Pseudomonas aeruginosa (moderate growth), Staphylococcus aureus |
Ciprofloxacin, cefaperazone |
No |
3 months |
45 |
65 |
F |
MOE |
152 |
112 |
95 |
88 |
70 |
73 |
74 |
74 |
80 |
64 |
123 |
80 |
Yes |
Yes |
Aspergillus fumigatus |
Cefaperazone, ciprofloxacin, voriconazole |
No |
Lost for follow up after 6 weeks |
46 |
71 |
M |
MOE |
47 |
70 |
13 |
31 |
26 |
2 |
90 |
100 |
97 |
90 |
80 |
19 |
Yes |
Yes |
Staph aureus, ryosporium sp. |
Voriconazole, terbinafine |
Yes |
6 months |
47 |
70 |
F |
MOE |
4.76 |
4.7 |
11.5 |
12 |
16.8 |
4.3 |
60 |
50 |
52 |
38 |
32 |
24 |
Yes |
No |
Pseudomonas aeruginosa (scanty growth) |
Ciprofloxacin, ceftazidime, |
No |
3 months |
48 |
57 |
M |
MOE |
24.9 |
1,3 |
22.4 |
80.9 |
52 |
34 |
38 |
30 |
24 |
18 |
20 |
67 |
Yes |
Yes |
Pseudomonas aeruginosa (heavy growth) |
Ceftazidime, piperacillin |
Yes |
Lost for follow up after 4 months |
48 |
62 |
F |
Central SBO |
12 |
6.1 |
5.5 |
10 |
2.32 |
1.38 |
30 |
44 |
50 |
19 |
52 |
27 |
Yes |
No |
Pseudomonas aeruginosa, cryosporium |
Ceftazidime, ciprofloxacin |
Yes |
2 months |
50 |
69 |
M |
Central SBO |
31 |
13 |
34 |
98 |
108 |
10 |
81 |
42 |
42 |
44 |
34 |
20 |
Yes |
No |
Aspergillus flavus |
Ciprofloxacin, cefaperazone, itraconazole |
No |
3 months |
51 |
88 |
M |
Central SBO |
22.56 |
|
|
|
|
8.4 |
70 |
|
|
|
|
60 |
|
No |
Pseudomonas aeruginosa |
Ceftazidime, ciprofloxacine |
No |
3 months |